EAST-ASIA PHARMACEUTICAL: The raw material drug Cefotiam has obtained the raw material drug registration certificate in South Korea
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, EAST-ASIA PHARMACEUTICAL announced that its wholly-owned subsidiary, Zhejiang Dongbang Pharmaceutical Co., Ltd., has recently received the active pharmaceutical ingredient registration certificate from the Korean Ministry of Food and Drug Safety (Korean MFDS). The product name is Cefotaxime Probenecid, which is a third-generation cephalosporin antibiotic used to treat infections of the respiratory tract, urinary system, biliary tract, and skin soft tissues caused by sensitive bacteria
According to the Zhitong Finance APP, EAST-ASIA PHARMACEUTICAL (605177.SH) announced that its wholly-owned subsidiary, Zhejiang Dongbang Pharmaceutical Co., Ltd., recently received the active pharmaceutical ingredient registration certificate from the Korean Ministry of Food and Drug Safety (Korea MFDS). The product name is Cefotaxime Probenecid, which is a third-generation cephalosporin antibiotic used to treat infections of the respiratory tract, urinary system, biliary tract, and skin soft tissues caused by sensitive bacteria